• GMP Sertifikalı Hiperest Önleyici Losartan Potasyum Tablet
  • GMP Sertifikalı Hiperest Önleyici Losartan Potasyum Tablet
  • GMP Sertifikalı Hiperest Önleyici Losartan Potasyum Tablet
  • GMP Sertifikalı Hiperest Önleyici Losartan Potasyum Tablet
  • GMP Sertifikalı Hiperest Önleyici Losartan Potasyum Tablet
  • GMP Sertifikalı Hiperest Önleyici Losartan Potasyum Tablet

GMP Sertifikalı Hiperest Önleyici Losartan Potasyum Tablet

Type: Organic Chemicals
Function: hiper edici
Main Ingredient: Losartan Potassium
Group: Elderly, Adult
Certification: CE, MSDS, GMP, ISO9000
Quality Guarantee Period: Three Years

Tedarikçi ile İletişime Geçin

Altın Üye Fiyat 2021

Doğrulanmış işletme lisanslarına sahip tedarikçiler

Ticari Şirket
  • Genel bakış
  • Product Description
  • Indication
  • Our service
  • Company Profile
Genel bakış

Temel bilgiler.

Hayır. Modeli.
Losartan Potassium Tablet
Store Method
Normal Temperature
uygulama
hiper edici
Taşıma Paketi
Box and Carton
Teknik Özelikler
25 mg
Ticari Marka
Without
Menşei
China
Üretim Kapasitesi
500000pieces/Years

Ürün Açıklaması

Product Description
Product Name Losartan Potassium tablet
Origin China
Specification 25 mg
Transport Packing 5 X 10's per box
Storage Keep in a cool, dry, dark location
Indication

As a angiotensin II receptor antagonist, Losartan Potassium is the potassium salt of losartan with antihypertensive activity, which is mainly used in the therapy of high blood pressure (hypertension) and diabetic nephropathy. It functions by relaxing blood vessels so that blood can flow more easily. It is also effective to help protect the kidneys from damage caused by diabetes and lower the risks of stroke in patients suffering from hypertension and myocardial enlargement. Besides, recent study has suggested that losartan is beneficial to reverse age related dysfunction in maintaining normal blood pressure and cellular energy usage on mitochondria and it can probably be used to treat left ventricular hypertrophy. It may also be used as an alternative agent for the treatment of systolic dysfunction, myocardial infarction, coronary artery disease, and heart failure.

Our service
1.Free professional and creative artwork design.
2.OEM service.
3.Registration documents supported.
4.Packing as your request, with photo before shipment.
Company Profile

Hebei Tenas Medicine I&E Inc. is located in Shijiazhuang City. It is a professional enterprise engaged in the research, development and production of pharmaceutical product.

Tenas was founded in 2018, and its predecessor was founded in 1998. In the past 20 years, it has only made pharmaceutical product, and accumulated rich experience in production, quality and management. With all the staff's hard work, the products have been exported to Africa, South America, Central America, Middle East countries, some CIS areas, Southeast Asia, etc, enjoying good reputation of their high quality and reasonable price. More than 200 kinds of products have been registered outside China. The factory was established with the GMP standard and passed more than 20 countries MOH Inspection.
Tenas takes "quality leading, technology leading, cost leading and service leading" as its business philosophy. "Make good medicine in the world, and make human health more guaranteed!"

Tenas is willing to provide you with a wide variety, complete specifications and excellent quality of Pharmaceutical product; And is willing to sincerely join hands with you to make contributions to the cause of human health!
 
GMP Certified Antihypertensive Losartan Potassium Tablet

 

Sorgunuzu doğrudan bu sağlayıcıya gönderin

*İtibaren:
*Şuradan:
*Mesaj:

Lütfen 20 ila 4000 karakter arasında girin.

Aradığınız şey bu değil? Satın Alma talebini Şimdi Yayınla

Kategoriye Göre Benzer Ürünleri Bulun

Tedarikçi Ana Sayfası Ürünler Ilaçtan Tablets GMP Sertifikalı Hiperest Önleyici Losartan Potasyum Tablet

Bunları Da Beğenebilirsiniz

Tedarikçi ile İletişime Geçin

Altın Üye Fiyat 2021

Doğrulanmış işletme lisanslarına sahip tedarikçiler

Ticari Şirket
Çalışan Sayısı
11
Kuruluş Yılı
2014-04-04